Remove 2017 Remove Conditions Remove Treatment
article thumbnail

Which States Offer Medical Cannabis For Mental Health Conditions?

Veriheal

According to the 2021 State of Mental Health in America by nonprofit organization Mental Health America (MHA), 19% of adults experienced a mental illness between 2017 and 2018, an increase of 1.5 One of the major obstacles many with a mental illness face is access to and affordability of treatment and resources. Anorexia, PTSD.

article thumbnail

The Top Medical Cannabis Research of 2017

MGC Pharma

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Marijuana Legalization Linked to Decline in Youth Drug Treatment Admissions

CannaMD

Researchers from Temple University sought to find out how recreational marijuana legalization in Washington and Colorado influenced adolescent treatment admissions for cannabis. MARIJUANA LEGALIZATION & YOUTH DRUG TREATMENT ADMISSIONS. Why Are Less Teens Treated for Cannabis Use Disorder in Legalized States?

Treatment 104
article thumbnail

Serious Conditions Are Responding To Cannabinoid Therapy

Peninsula Alternative Health

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Following the treatment period, there was a 35.5% tetrahydrocannabinol (THC).

article thumbnail

From MMJ to Special K

Project CBD

There’s no doubt that cannabis helps Rosenfeld’s condition, but it’s not a cure. Impaired neurogenesis has been linked to clinical depression, substance abuse, and other mental health conditions. Another major drawback: MediCare and health insurance companies don’t cover ketamine treatments, so patients must pay out of pocket.

article thumbnail

BetterLife Files Patent for TD-0148A for Treatment of Cluster Headaches and Related Disorders

Cannabis Law Report

We are excited to be developing and bringing to market treatments addressing cluster headaches, neuropathic pain and range of mental health conditions, including depression, anxiety and PTSD, and related disorders.”. billion in 2017 (from US$3.48 billion industry by 2027. About BetterLife Pharma. BetterLife Pharma Inc.

article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.